- Home
- CRBP vs CSLR Comparison
CRBP vs CSLR Comparison
Compare CRBP & CSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- CSLR
- Stock Information
- Founded
- CRBP 2009
- CSLR 2022
- Country
- CRBP United States
- CSLR United States
- Employees
- CRBP N/A
- CSLR N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- CSLR Semiconductors
- Sector
- CRBP Health Care
- CSLR Technology
- Exchange
- CRBP Nasdaq
- CSLR Nasdaq
- Market Cap
- CRBP 143.7M
- CSLR 133.5M
- IPO Year
- CRBP N/A
- CSLR N/A
- Fundamental
- Price
- CRBP $11.93
- CSLR $1.85
- Analyst Decision
- CRBP Strong Buy
- CSLR Buy
- Analyst Count
- CRBP 8
- CSLR 1
- Target Price
- CRBP $62.00
- CSLR $6.00
- AVG Volume (30 Days)
- CRBP 256.8K
- CSLR 411.1K
- Earning Date
- CRBP 03-11-2025
- CSLR 11-13-2024
- Dividend Yield
- CRBP N/A
- CSLR N/A
- EPS Growth
- CRBP N/A
- CSLR N/A
- EPS
- CRBP N/A
- CSLR N/A
- Revenue
- CRBP N/A
- CSLR $40,797,000.00
- Revenue This Year
- CRBP N/A
- CSLR N/A
- Revenue Next Year
- CRBP N/A
- CSLR $220.32
- P/E Ratio
- CRBP N/A
- CSLR N/A
- Revenue Growth
- CRBP N/A
- CSLR N/A
- 52 Week Low
- CRBP $7.30
- CSLR $0.20
- 52 Week High
- CRBP $61.90
- CSLR $3.37
- Technical
- Relative Strength Index (RSI)
- CRBP 39.08
- CSLR 55.00
- Support Level
- CRBP $11.02
- CSLR $1.58
- Resistance Level
- CRBP $13.28
- CSLR $2.00
- Average True Range (ATR)
- CRBP 0.74
- CSLR 0.13
- MACD
- CRBP 0.16
- CSLR 0.00
- Stochastic Oscillator
- CRBP 40.27
- CSLR 65.91
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About CSLR Complete Solaria Inc.
Complete Solaria Inc is a solar company with unique technology and end-to-end customer offering, which includes financing, project fulfilment and customer service. Complete Solaria's digital platform together with premium solar products enable one-stop service for clean energy needs for customers wishing to make the transition to a more energy-efficient lifestyle.